Aemetis Reports Q3 Revenue Increase to $59.2 Million Driven by Dairy RNG and Biodiesel Sales
Reuters
Nov 14, 2025
Aemetis Reports Q3 Revenue Increase to $59.2 Million Driven by Dairy RNG and Biodiesel Sales
Aemetis Inc. reported third-quarter 2025 revenue of $59.2 million, an increase of $7 million from the previous quarter, driven by stronger California ethanol margins and $14.5 million in biodiesel sales to India. The company's Dairy RNG platform generated approximately $4 million in revenue from 114,000 MMBtu produced by 12 operating digesters, with full monetization of seven newly approved LCFS pathways. Cash at quarter end rose to $5.6 million as Aemetis advanced a $30 million MVR project at Keyes, expected to add around $32 million in annual cash flow. The company has signed $57 million in equipment and installation contracts year-to-date and anticipates RNG production capacity to reach 550,000 MMBtu by year end, increasing to 1.0 million MMBtu by fiscal year 2027. Monetization pathways now include the sale of RNG molecules, D3 RINs, and Section 45Z production tax credits.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aemetis Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 274514) on November 14, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.